Editas Medicine, Inc. (EDIT)

Editas Medicine Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	373	827	610	1,816	4,370	1,519
Market Cap Growth	21.40%	35.65%	-66.41%	-58.45%	187.69%	39.66%
Enterprise Value	111	541	310	1,343	3,994	1,091
PE Ratio	-	-5.40	-2.77	-9.43	-37.68	-11.36
PS Ratio	5.38	10.59	30.94	71.09	48.17	73.99
PB Ratio	1.27	2.37	1.69	3.28	11.10	5.79
P/FCF Ratio	-4.02	-6.04	-3.36	-10.57	-23.37	-32.50
P/OCF Ratio	-4.15	-6.26	-3.44	-11.09	-24.30	-37.35
EV/Sales Ratio	1.60	6.92	15.71	52.56	44.02	53.14
EV/EBITDA Ratio	-1.92	-3.28	-1.41	-7.14	-34.85	-7.89
EV/EBIT Ratio	-1.86	-3.17	-1.37	-6.95	-33.68	-7.73
EV/FCF Ratio	-2.28	-3.95	-1.71	-7.82	-21.36	-23.35
Debt / Equity Ratio	0.12	0.10	0.12	0.05	0.07	0.11
Debt / EBITDA Ratio	-0.19	-0.22	-0.20	-0.14	-0.23	-0.21
Debt / FCF Ratio	-0.23	-0.27	-0.24	-0.15	-0.14	-0.62
Quick Ratio	4.46	5.27	5.81	10.67	7.01	7.63
Current Ratio	4.60	5.39	5.94	10.82	7.20	7.74
Asset Turnover	0.14	0.16	0.04	0.04	0.16	0.05
Return on Equity (ROE)	-47.30%	-43.00%	-50.30%	-32.20%	-31.00%	-60.60%
Return on Assets (ROA)	-33.50%	-30.50%	-39.20%	-26.30%	-20.20%	-33.10%
Return on Capital (ROIC)	-56.37%	-43.87%	-55.84%	-33.30%	-32.13%	-48.34%
Earnings Yield	-44.50%	-18.52%	-36.14%	-10.60%	-2.65%	-8.80%
FCF Yield	-40.45%	-16.55%	-29.75%	-9.46%	-4.28%	-3.08%
Buyback Yield / Dilution	-18.88%	-10.63%	-1.55%	-15.37%	-17.26%	-6.13%
Total Shareholder Return	-18.88%	-10.63%	-1.55%	-15.37%	-17.26%	-6.13%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).